(1)
Kulumbegov, B.; Gotua, M.; Chikovani, T. Type I and Type IIb Autoimmunity in Chronic Spontaneous Urticaria Patients: Evaluating the Clinical Response to Omalizumab. GS 2023, 5, 109-116.